Back to available technologies

Search our Available Technologies

By Clinical Application > Blood & Lymphatic Disease

A method for predicting the responsiveness of lymphomas to PI3K pathway inhibitors

Value Proposition Lymphomas are highly diverse and among the most...

MORE >

MEK inhibitors as therapeutic agents and diagnostic tools for hemoglobinopathies, including thalassemia

Value Proposition Patients with sickle cell disease experience acute vaso-occlusive...

MORE >

RNA Aptamers Targeting a coagulation Cascade Cofactor

Value Proposition Thrombosis (blood clots within blood vessels) is a...

MORE >

RNA aptamers for thrombi imaging

Value Proposition Thrombosis (blood clots within blood vessels) is a...

MORE >